Kidney Disease Clinical Trials

Showing 3641-3660 of 3,902 trials

A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease

NCT01452360

This project expects the integrated database of terminally renal ill patients combines clinical and files of Health Insurance and renal medical society database. It will provide valuable actual evidence data to quality monitoring of dialysis treatment and related academic research. Besides, using the cohort study of chronic renal disease --「epidemiologic research of chronic renal disease」, we can trace the patient continually and analysis different risk factors of chronic renal disease in Taiwan. Taken together, the results of this project --1.1「Integrate the current database of renal disease and establishment of national monitor system」and 1.2「Epidemiologic study in chronic renal disease」-- will provide the basic rules of prevention and treatment, basic research and clinic application in chronic renal disease.

Chronic Kidney Disease

Taipei Medical University WanFang Hospital700 participantsStarted May 2011

Taipei, Taiwan

UNKNOWNPhase 4

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

NCT00777504

The purpose of this study is to determine if and how often an unexpected fast increase of disease and complaints shows after stopping the anti-angiogenetic therapy

Renal Cell CarcinomaGastrointestinal Stromal Tumor

Radboud University Medical Center30 participantsStarted Oct 2008

Nijmegen, Gelderland, Netherlands

COMPLETEDPhase 1/2

Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease

NCT00692562

The aim of this study was to evaluate the efficiency and safety of simultaneous islet-kidney transplantation in patients of type 1 diabetes with end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction. Islet transplantation can result in insulin independence with excellent metabolic control when glucocorticoid-free immunosuppression is combined with the infusion of an adequate islet mass. Alemtuzumab (Campath-1H ®) is a 150-kDa humanized IgG1 monoclonal antibody that targets the CD52 antigen. Prolonged lymphocyte depletion can be expected following alemtuzumab treatment.

Type 1 Diabetes MellitusEnd-stage Renal Disease

Fuzhou General Hospital7 participantsStarted Jun 2005

Fuzhou, Fujian, China

A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease

Related Searches

Inulin and Protein Fermentation in Hemodialysis Patients

Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2

Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate

Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease

Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease (CKD)- ELPD Study

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Salivary Phosphorus and Level of Kidney Function

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

Caregivers and Electronic Medication Monitoring in Chronic Kidney Disease

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

A Study of Fostamatinib in Subjects With Impaired Kidney Function